Lipophilic β-Blockers and Suicide in the Elderly.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences and Li Ka Shing Knowledge Institute, St Michael's Hospital and Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences and Li Ka Shing Knowledge Institute, St Michael's Hospital and Institute of Health Policy Management, and Evaluation, University of Toronto and Applied Health Research Centre, St Michael's Hospital, Toronto, Ontario, Canada and King Saud University, Riyadh, Saudi Arabia; Institute for Clinical Evaluative Sciences and Institute of Health Policy, Management and Evaluation, University of Toronto and Department of Family Medicine, McMaster University Hamilton, Ontario, Canada, Canada; Department of Medicine, Sunnybrook Health Sciences Centre and Institute for Clinical Evaluative Sciences and Institute of Health Policy, Management and Evaluation, University of Toronto and Sunnybrook Research Institute, Toronto, Ontario, Canada. dnj@ices.on.ca.
Jonathan S
JS
Zipursky
Erin M
EM
Macdonald
Jin
J
Luo
Tara
T
Gomes
Muhammad M
MM
Mamdani
J Michael
JM
Paterson
David N
DN
Juurlink
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008297:Male; D009864:Ontario / Q000453:epidemiology; D013405:Suicide / Q000706:statistics & numerical data*
D000319:Adrenergic beta-Antagonists